GLATIRAMER ACETATE
Generic: GLATIRAMER ACETATE INJECTION
UPSHER-SMITH LABORATORIESManufacturer
SUBCUTANEOUSRoute
GLATIRAMER ACETATEActive Substance
2025-12-31Original Approval
GLATIRAMER ACETATE is FDA application ANDA214741, sponsored by SCINOPHARM TAIWAN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
INJECTION SITE PAIN
780 reports
2
MULTIPLE SCLEROSIS
649 reports
3
DRUG INEFFECTIVE
613 reports
4
MULTIPLE SCLEROSIS RELAPSE
592 reports
5
INJECTION SITE ERYTHEMA
425 reports
6
INJECTION SITE MASS
370 reports
7
FATIGUE
335 reports
8
INJECTION SITE SWELLING
316 reports
9
DYSPNOEA
315 reports
10
INJECTION SITE PRURITUS
265 reports